Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | 150 mg Abemaciclib + Endocrine Therapy | 634 | 2,791 | 862 |
| other | Anaemia | Blood and lymphatic system disorders | Endocrine Therapy | 88 | 2,800 | 113 |
| other | Leukopenia | Blood and lymphatic system disorders | 150 mg Abemaciclib + Endocrine Therapy | 1,026 | 2,791 | 1,706 |
| other | Leukopenia | Blood and lymphatic system disorders | Endocrine Therapy | 171 | 2,800 | 244 |
| other | Lymphopenia | Blood and lymphatic system disorders | 150 mg Abemaciclib + Endocrine Therapy | 372 | 2,791 | 527 |
| other | Lymphopenia | Blood and lymphatic system disorders | Endocrine Therapy | 94 | 2,800 | 118 |
| other | Neutropenia | Blood and lymphatic system disorders | 150 mg Abemaciclib + Endocrine Therapy | 1,246 | 2,791 | 2,316 |
| other | Neutropenia | Blood and lymphatic system disorders | Endocrine Therapy | 140 | 2,800 | 214 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | 150 mg Abemaciclib + Endocrine Therapy | 341 | 2,791 | 528 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Endocrine Therapy | 39 | 2,800 | 48 |
| other | Palpitations | Cardiac disorders | 150 mg Abemaciclib + Endocrine Therapy | 54 | 2,791 | 62 |
| other | Palpitations | Cardiac disorders | Endocrine Therapy | 20 | 2,800 | 22 |
| other | Vertigo | Ear and labyrinth disorders | 150 mg Abemaciclib + Endocrine Therapy | 70 | 2,791 | 93 |
| other | Vertigo | Ear and labyrinth disorders | Endocrine Therapy | 47 | 2,800 | 55 |
| other | Hypothyroidism | Endocrine disorders | 150 mg Abemaciclib + Endocrine Therapy | 28 | 2,791 | 29 |
| other | Hypothyroidism | Endocrine disorders | Endocrine Therapy | 34 | 2,800 | 34 |
| other | Dry eye | Eye disorders | 150 mg Abemaciclib + Endocrine Therapy | 71 | 2,791 | 76 |
| other | Dry eye | Eye disorders | Endocrine Therapy | 28 | 2,800 | 31 |
| other | Lacrimation increased | Eye disorders | 150 mg Abemaciclib + Endocrine Therapy | 137 | 2,791 | 158 |
| other | Lacrimation increased | Eye disorders | Endocrine Therapy | 10 | 2,800 | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events